“…Taken together, our study indicates that Propiverine-N-oxide was also found to be the major metabolite formed in rats when administered orally, thus suggesting a similar pharmacological handling in humans and rats (Yamada et al 2010). In order to attain drug approval for propiverine in Japan and later in the EU, preclinical testing was carried out in mice, rats and dogs (Inoue et al 1989;Kohda et al 1989;Nakano et al 1989;Yamashita et al 1989Yamashita et al , 1990. In both the 13-and 52-week oral dosing study, rats presented with striking renal pathological changes: Propiverine treatment resulted in prominent protein accumulation in the cytosol and nuclei of proximal tubule epithelial cells Yamashita et al 1990).…”